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Skin malignancy is an important cause of mortality in the United Kingdom and is rising in incidence every year. Most skin cancer
presents in primary care, and an important determinant of outcome is initial recognition and management of the lesion. Here we
present an observational study of interobserver agreement using data from a population-based randomised controlled trial of minor
surgery. Trial participants comprised patients presenting in primary care and needing minor surgery in whom recruiting doctors felt to
be able to offer treatment themselves or to be able to refer to a colleague in primary care. They are thus relatively unselected. The
skin procedures undertaken in the randomised controlled trial generated 491 lesions with a traceable histology report: 36 lesions
(7%) from 33 individuals were malignant or pre-malignant. Chance-corrected agreement (k) between general practitioner (GP)
diagnosis of malignancy and histology was 0.45 (0.36–0.54) for lesions and 0.41 (0.32–0.51) for individuals affected with malignancy.
Sensitivity of GPs for the detection of malignant lesions was 66.7% (95% confidence interval (CI), 50.3–79.8) for lesions and 63.6%
(95% CI, 46.7–77.8) for individuals affected with malignancy. The safety of patients is of paramount importance and it is unsafe to
leave the diagnosis and treatment of potential skin malignancy in the hands of doctors who have limited training and experience.
However, the capacity to undertake all of the minor surgical demand works demanded in hospitals does not exist. If the capacity to
undertake it is present in primary care, then the increased costs associated with enhanced training for general medical practitioners
(GPs) must be borne.
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The United Kingdom has a health service divided into two distinct
components. The large majority of people are registered with a GP
who is the first point of contact with the service. There is no direct
route to secondary care except through private consultation for a
minority, or through the emergency room. Ever since the 1990
contract for GPs in England and Wales that specified an item of
service payment for minor surgical procedures, there has been
fierce debate about the quality and appropriateness of manage-
ment decisions and clinical practices in general practice, focussing
around two issues (Paraskevopoulos et al, 1988; Department of
Health & The Welsh Office, 1989; Brazier and Lowy, 1991; Bull
et al, 1991; McWilliam et al, 1991; Brown et al, 1992; Cox et al,
1992; Bricknell, 1993; Lowy et al, 1997, 1998; Cross, 1998; Khorshid
et al, 1998; Kirby et al, 1998; Suvarna et al, 1998). First is the
technical quality of surgery performed, discussed most often in
terms of incomplete excision of malignant or pre-malignant
conditions, and which we have addressed in a population-based
randomised controlled trial of minor surgery (George et al).
Intimately associated with this is the second issue, the accuracy of
clinical diagnosis and the consequent need for histological
confirmation of diagnosis. Until now, there has been a relative
absence of firm UK evidence: what evidence exists comprises
descriptions of personal case series from general practice, and
audits of completely or incompletely excised lesions reported by
pathologists, with or without accurate diagnoses recorded on the
pathologist’s request form.
In a population-based randomised controlled trial of minor
surgery, we identified that GPs make less use of pathology services
than do hospital doctors (George et al). We have been unable to
identify population-based studies comparing clinical diagnosis in
primary care and laboratory histology in the United Kingdom.
This paper aims to establish how well GPs recognise skin cancer,
using data from our trial.
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sMATERIALS AND METHODS
Data
This study used data on pathological samples collected during a
population-based randomised controlled trial comparing the
quality of minor surgery performed by GPs and hospital doctors
(George et al). All patients recruited to the trial had a GP referral
form indicating a working diagnosis for the lesion concerned.
These working diagnoses were entered into a database, along with
the histological diagnosis found on the histology form pertaining
to the sample, where one was found. Multiple searches were
undertaken in each of the pathology departments serving the area
from which patients were recruited over the whole period of the
trial to find these reports. There were many diagnoses on both
referral forms and pathology reports, and we divided them into 23
categories, using a classification derived from Rook’s Textbook of
Dermatology, Sixth edition (Champion et al, 1998). The categories
arrived at are shown in Tables 1 and 2. We excluded ingrowing
toenails from all aspects of the ensuing analysis, leaving 22
categories of lesion. These were further collapsed into ‘benign’ and
‘malignant’ categories for analysis. The ‘malignant’ category
comprised three malignancies (malignant melanoma, squamous
cell carcinoma and basal cell carcinoma), one low-grade malig-
nancy (keratoacanthoma) and one pre-malignant condition
(Bowen’s disease).
Analysis
Chance-corrected, inter-rater reliability was measured using
Cohen’s k in Stata 9.0 (Stata Corp). A k value greater than 0.75
Table 1 Number of cases as described by GPs on referral form, numbers in
whom a procedure can be shown to have been performed and numbers of those in whom a histological sample was found, by trial arm
Histological sample found
GP’s description Total with GP diagnosis Total operated upon Hospital group Primary care group
Lesions analysed
1 Unknown/nonspecific description 14 14 6/7 7/7
2 Eczema/dermatitis 0 0 0/0 0/0
3 Granuloma 8 6 4/4 2/2
4 Solar elastosis 0 0 0/0 0/0
6 Sebaceous gland hyperplasia 1 1 0/0 1/1
7 Skin tag, fibroepithelial polyp, skin polyp 58 55 14/20 10/35
8 Chondrodermatitis nodularis helices 0 0 0/0 0/0
9 Viral warts 12 12 5/5 7/7
10 Scars including keloid 2 2 1/1 1/1
11 Benign tumours including neurofibroma 32 30 13/13 12/17
12 Lipoma 19 17 6/7 4/10
13 Trichilemmal cysts and epidermoids 157 143 74/90 30/53
14 Lentigo 0 0 0/0 0/0
15 Seborrhoeic keratosis, seborrhoeic wart, BCP 148 138 57/79 43/59
16 Melanocytic naevus 159 150 66/72 62/78
17 Solar keratosis 4 4 2/2 2/2
18 Cutaneous horn 1 1 0/0 1/1
19 Bowen’s disease 1 1 1/1 0/0
20 Basal cell carcinoma 51 45 21/21 23/24
21 Keratoacanthoma 4 4 3/3 1/1
22 Squamous cell carcinoma 8 7 3/3 4/4
23 Malignant melanoma 4 4 1/1 3/3
Total 683 634 277/329 (84%) 213/305 (70%)
Lesions not analysed
5 Ingrown toenail 18 17 0/9 0/8
No procedure undertaken or referred elsewhere 28 23
Not referred by GP 2 1 1/1 0/0
No data on referral form 2 2 0/2 0/0
Grand Total 705 654 369 336
GP¼general practitioner.
Table 2 Comparison of numbers (%) in each histological category as
described by GPs and as classified by histological examination (ingrowing
toenails not displayed)
GP
diagnosis
Histological
diagnosis
1 Unknown/nonsense description 13 (2.6) 0
2 Eczema/dermatitis 0 2 (0.4)
3 Granuloma 6 (1.2) 12 (2.4)
4 Solar elastosis 0 9 (1.8)
6 Sebaceous gland hyperplasia 1 (0.2) 1 (0.2)
7 Skin tag, fibroepithelial polyp, skin polyp 24 (4.7) 27 (5.3)
8 Chondrodermatitis nodularis helices 0 1 (0.2)
9 Viral warts 12 (2.4) 15 (2.9)
10 Scars including keloid 2 (0.4) 1 (0.2)
11 Benign tumours including neurofibroma 25 (4.9) 64 (12.6)
12 Lipoma 10 (2.0) 11 (2.2)
13 Cysts including epidermoids 104 (20.4) 72 (14.1)
14 Lentigo 0 7 (1.4)
15 Seborrhoeic keratosis, seborrhoeic wart,
BCP
100 (19.6) 93 (18.5)
16 Melanocytic naevus 128 (25.1) 134 (26.3)
17 Solar keratosis 4 (0.8) 4 (0.8)
18 Cutaneous horn 1 (0.2) 0
19 Bowen’s disease 1 (0.2) 3 (0.6)
20 Basal cell carcinoma 44 (8.6) 26 (5.1)
21 Keratoacanthoma 4 (0.8) 1 (0.2)
22 Squamous cell carcinoma 7 (1.4) 5 (1.0)
23 Malignant melanoma 4 (0.8) 2 (0.4)
Total 490 490
GP¼general practitioner. Figures in the second column are not a subset of figures
in the first column.
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sis considered excellent agreement beyond chance, values below
0.40 represent poor agreement, and values between 0.40 and 0.75
represent fair-to-good agreement (Fleiss, 1981). The sensitivity,
specificity and positive predictive value for GPs’ recognition of
skin malignancies were calculated with 95% confidence intervals
(CIs). We did not run a sensitivity analysis on the data as missing
cases greatly outnumbered known malignancies, and it was felt
that the assumption that all missing cases were malignant was
unlikely. In the group of malignancies in which surgery was
undertaken by the GP, we used cross-tabulation to examine
whether recognition of the lesion as malignant had an effect on
completeness of excision.
RESULTS
Five hundred and sixty-eight individuals entered the trial, which
generated these data by 82 GPs. Their average age was 48.75 years,
and 309 of them (54.4%) were women. Sixty-five GPs undertook
surgery in the primary care arm of the trial and 60 hospital
surgeons or dermatologists in the hospital arm. Of 705 lesions, 654
can be shown to have been subject to a procedure, 17 of these
involving ingrowing toenails in which histology is not usually
performed and which were excluded from later analysis. Overall,
491 of the 637 skin procedures (77%) generated a traceable
pathology report. Table 1 shows numbers of these cases by
diagnosis as described by the GPs and number in each category in
which a histological sample was found by trial arm. In one case,
there was no referral from the GP, the procedure having been
performed at the request of a patient with multiple lesions and in
whom that lesion had not been mentioned in the referral. This
lesion was excluded, leaving 490 for further analysis. The table
demonstrates that the deficit in samples does not follow a random
pattern. However, although it might be expected that skin tags
would be under-represented, shortfalls in other categories, which
can sometimes closely resemble malignancies (e.g. basal cell
papillomata, melanocytic naevi), are more worthy of concern.
Table 2 shows the numbers of cases in which a histological sample
was found as described by GPs and as classified by histological
examination (ingrowing toenails excluded).
Agreement between GP diagnosis and histology
An overall k statistic of 0.45 (95% CI, 0.36–0.54) was obtained for
agreement between GP diagnosis and later histology. Even at its
upper 95% CI, therefore, agreement is moderate at best. Four of
the lesions (all basal cell carcinomas) were diagnosed, correctly, in
the same individual, and it may be possible that the finding of one
malignancy lesion pre-disposes the examiner to find others. If k is
recalculated to reflect individuals correctly diagnosed with
malignancy, rather than lesions, the resulting statistic is 0.41
(0.32–0.51). Again, even at the upper level of statistical confidence,
agreement is ‘moderate’ at best.
Test characteristics of GPs in detecting skin malignancy
The results above can be expressed as 2 2 tables and test
characteristics (sensitivity, specificity, predictive values) were
computed. Sensitivity is calculated as the proportion (or percen-
tage) of malignancies correctly diagnosed, whereas specificity is
the proportion (or percentage) of non-malignancies correctly
diagnosed. A positive predictive value is the proportion of positive
diagnoses that correctly identify a malignancy and a negative
predictive value the proportion (or percentage) of negative
diagnoses that correctly exclude one. Table 3 shows the data for
individual lesions, with test characteristics computed below, and
Table 4 is the analogous table for individuals affected with
malignancy. The results do not differ a great deal between the two
analyses. They indicate that, in our population, GPs failed to
recognise one-third of the skin malignancies, or slightly more than
one-third of the patients with malignancies. Taking statistical
uncertainty into account, the upper 95% CI for both analyses
indicates that they miss no fewer than one in five. Neither of the
malignant melanomas included here was diagnosed by the GP
concerned: one was described as a ‘dermatofibroma’ and the other
given a general description as ‘red lesion’. A further two
malignancies do not form part of this data set: although
randomised they were lost to follow-up because hospital doctors
judged that they did not meet an inclusion criterion, which was
that the GPs should feel to be able to offer treatment themselves or
to be able to refer to a colleague in primary care. Neither case was
felt to be suitable for treatment within the context of a hospital
minor surgery unit, and both were referred for specialist
treatment. One was a squamous cell carcinoma in a ‘difficult’ area
and the other a large malignant melanoma that had presented on
multiple occasions before referral.
DISCUSSION
Not all malignant lesions are clinically obvious at presentation, and
some have potentially serious adverse outcomes if missed. In this
study, GPs missed a third of malignancies, including both
malignant melanomas, and two further malignancies were
excluded at an earlier stage because of the lack of recognition of
what they were. Clearly, more study is required: these data were
collected in the highly artificial environment of a controlled trial
and, despite some evidence to the contrary, it may be that all the
malignancies unrecognised here would have been referred to
specialist care under a 2-week waiting rule in a real-world
situation. However, although confined to one geographical area
of the United Kingdom, this study was population based and
included patients referred by a large number of GPs, and we
believe the results to be generalisable. It is reassuring for us, but
perhaps not for patients, that our results are echoed in studies
from other countries. Whited et al (1997) showed that primary
care clinicians identified the presence of skin cancer with a
sensitivity of 57% (95% CI, 44–68%) in one US study and
Table 3 Benign and malignant skin lesions as judged by histology and by
GP diagnosis
Histology
malignant
Histology
benign Total
GP diagnosis malignant 24 36 60
GP diagnosis benign 12 416 428
Total 36 452 488
GP¼general practitioner. Sensitivity¼66.7% (52.9–78.00). Specificity¼92.0%
(89.7–93.9). Positive predictive value¼40% (30.2–50.6). Negative predictive
value¼97.2% (93.6–98.2).
Table 4 Individuals classified by whether they were judged to have a
malignant skin lesion as judged by histology and by GP diagnosis
Histology
malignant
Histology
benign Total
Malignant diagnosis by GP 21 35 56
No malignant diagnosis by GP 12 355 367
Total 33 390 423
GP¼general practitioner. Sensitivity¼63.6% (49.3–75.4). Specificity¼91.0%
(88.5–93.1). Positive predictive value¼37.5% (27.6–48.5). Negative predictive
value¼96.7% (94.8–98.0).
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clinicians’ examinations may be ineffective as a screening test’.
Youl et al (2007) in Australia found that although, overall,
sensitivity for diagnosing any skin cancer was similar for skin
cancer clinic doctors (94%) and GPs (91%), sensitivity was higher
for skin cancer clinic doctors for BCC (89 vs 79%; Po0.01) and
melanoma (60 vs 29%; Po0.01). Raasch (1999), again in Australia,
showed a sensitivity of 69.1% (95% CI, 62.5–75.7%) for primary
care doctors in a series of non-melanoma skin malignancies. But
what should the sensitivity be? Perfection, after all, is not easy to
attain. True comparisons between dermatologists’ and primary
care physicians’ accuracy in diagnosing melanoma are uncommon,
but one systematic review showed a bottom end of the range of
values of sensitivity to malignant melanoma in dermatologists of
81%, but of only 41% in primary care physicians (Chen et al,
2001). In the face of rising skin cancer incidence it is clear that the
major challenge of providing minor surgery in primary care is the
potential for missed diagnosis of serious skin malignancies (Diffey,
2004).
The 1990 contract was changed in 2004 so that there are
stringent standards in place for those wishing to become general
practitioners with a special interest in dermatology (Shekelle,
2003). However, these individuals, analogous to the ‘skin cancer
clinic doctors’ in the study by Youl et al (2007), are not sufficient
in number to undertake the assessment of all minor skin lesions
presenting in primary care, and hospital services do not have the
capacity either. GPs who merely wish to be added to the minor
surgery list now have to be signed off by their trainer as
competent, competent, but standards are set locally. Clinical
guidelines issued by NICE make recommendations for referral of
patients with suspected cancer from primary care to specialist
services (National Institute for Health and Clinical Excellence,
2006). These guidelines recommend that patients presenting with
skin lesions suggestive of skin cancer, or in whom a biopsy has
been confirmed, should be referred to a team specialising in skin
cancer. However, it is not clear what will happen if GPs do not
suspect that a lesion is cancerous, as in one-third of the
malignancies in this study.
These results place an important ‘health warning’ around the
assumption that shifting services from secondary care to primary
care carries only benefits (Department of Health, 2006). There is
not the capacity in hospitals to take on the workload of minor
surgery or even of mere diagnosis of all skin lesions, and it would
likely be unpopular with patients if it were to happen (George
et al). We do not believe that the background of a doctor in general
practice, surgery or even dermatology is fundamentally important,
but we do believe that it is unsafe to leave the diagnosis and
treatment of potential skin cancer entirely in the hands of doctors
who have had insufficient training to do it. The increased costs
associated with developing and delivering appropriate training to
all GPs, not just for those with a specialist interest, must be
acknowledged and provided.
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